Self-supervised learning opens a new path for neuroimaging analysis in brain disorders: a review highlights key opportunities from data scarcity to clinical translation
image: The top represents the brain network pipeline, where raw neurological data is systematically processed to extract meaningful representations. The bottom highlights the core self-supervised model, comprising an encoder-decoder architecture. These refined representations are then utilized for downstream tasks, such as disease categorization, detection, and prediction. The model's bidirectional learning flow ensures robustness and adaptability across diverse neuroimaging datasets.
Credit: Harbin Institute of Technology, Shenzhen
Accurately identifying dysfunctional brain signatures is central to improving the early detection, classification, and prognosis assessment of brain disorders. Yet functional neuroimaging data, including functional magnetic resonance imaging and electroencephalography, are high-dimensional, structurally complex, and often limited by a shortage of high-quality labeled datasets. A research team from Harbin Institute of Technology (Shenzhen), the Tübingen Center for Mental Health in Germany, the International Research Institute for Artificial Intelligence at Harbin Institute of Technology (Shenzhen), and Peng Cheng Laboratory has published a review article in Health Data Science that systematically examines the methodological landscape, representative applications, and future directions of self-supervised learning in neuroimaging analysis for brain disorders.
The authors note that traditional supervised learning approaches typically depend on large quantities of sample-level annotations. In brain disorder research, however, annotation is costly, time-consuming, and often complicated by site differences, disease heterogeneity, and variability in data acquisition. Self-supervised learning offers a different route: by designing pretext tasks, it allows models to learn meaningful representations directly from large volumes of unlabeled data. In this sense, the approach is not simply a technical refinement but a potentially important shift in how neuroimaging models are trained for complex clinical questions.
The review focuses on 3 broad categories of self-supervised learning methods—contrastive learning, generative learning, and generative-contrastive learning—and discusses how they can be applied to functional MRI, EEG, and related brain network data. It highlights the potential of these methods in addressing long-standing challenges such as data scarcity, multimodal integration, and dynamic network modeling. The article also summarizes their applications in studies of Alzheimer’s disease, Parkinson’s disease, epilepsy, and other neuropsychiatric conditions, underscoring their promise for disease detection, prediction, and the extraction of clinically relevant neural representations.
At the methodological level, the value of self-supervised learning lies not only in reducing dependence on manual labels, but also in its ability to capture subtle, complex, and dynamic patterns of brain activity and connectivity. This could support the development of more robust, transferable, and scalable diagnostic and prognostic tools. For highly heterogeneous disorders and multisite datasets, that advantage may prove especially important. The authors emphasize that self-supervised learning should be understood not merely as a collection of techniques, but as a strategic bridge between artificial intelligence and the practical needs of neuroscience and clinical research.
The review does not overlook the obstacles ahead. It points to persistent challenges, including limited interpretability, strong heterogeneity across modalities and sites, missing modalities, the difficulty of validating synthetic data, and substantial computational demands. In clinical settings, model accuracy alone is not enough; researchers and clinicians also need evidence that model decisions are understandable and that the learned features carry biological and medical relevance.
Looking forward, the authors aim to develop more robust, interpretable, and clinically translatable self-supervised learning models, with particular attention to multimodal fusion, cross-site heterogeneity, and novel pretext-task design for specific brain disorders. They also call for validation in larger and more diverse clinical cohorts. Their longer-term goal is to help enable earlier and more accurate diagnosis, more personalized intervention strategies, and a deeper understanding of the neurobiological mechanisms underlying brain disorders.